Castle Biosciences, Inc. revenue breakdown overview

Castle Biosciences, Inc. revenue for the last year amounted to 219.79 M USD, the most of which — 183.38 M USD — came from its highest performing source at the moment, Dermatologic, the year earlier bringing 124.81 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Castle Biosciences, Inc. 219.79 M USD, and the year before that — 137.04 M USD.